Clinical Trial Update: Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating everolimus in patients with recurrent or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED